(In the Media) “Study group for the suitable drug information” recommended pharmaceutical industry (the Nikkei Medical, the July 2016 edition）
date : 7/1/2016
An article featuring a “Round-table discussion among those with ‘Study group for the suitable drug information’ recommended pharmaceutical industry.’ in which Toshio Miyata, HGPI Board Member participated, appeared in the July 2016 edition of the Nikkei Medical.
This study group is organized by Nikkei Medical and the member are 5 are doctors. They take more regulation of providing drug information seriously.
In the last four meetings, they were talking about desirable drug information. And this time, they recommended the suitable drug information for the pharmaceutical industry.
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
![[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_eyecatch_20260619_AMR_Recommendations.png)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
![[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient](https://hgpi.org/en/wp-content/uploads/sites/2/Kiyoshi-Kurokawa-Award_2nd_eyecatch_web.jpg)
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
![[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260722_PLH-Academy-2.png)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
![[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/ckd-ncd-20260731-top_ENG.png)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)
![[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)](https://hgpi.org/en/wp-content/uploads/sites/2/HGPI_20260930_The4th-J-PEPseminar.jpg)
